Company Filing History:
Years Active: 1994
Title: Jeffry D McGolrick: Innovator in Pharmaceutical Chemistry
Introduction
Jeffry D McGolrick is a notable inventor based in Aurora, California. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of ranitidine hydrochloride.
Latest Patents
McGolrick holds a patent for the "Preparation of form 1 ranitidine hydrochloride." This patent describes a process of crystallization from a solution of ranitidine hydrochloride in a mixed solvent. The solvent comprises one part by volume of at least one lower alkanol, such as ethanol, and one to two parts by volume of a C6-C10 aromatic hydrocarbon, such as toluene. The process is conducted in the presence of seed crystals of pure Form 1 ranitidine hydrochloride. In the preferred method, the ranitidine hydrochloride is prepared in situ in the solvent mixture by adding hydrochloric acid to a solution of the free base, along with the seed crystals.
Career Highlights
McGolrick is associated with Torcan Chemical Ltd, where he applies his expertise in chemical processes. His work has contributed to advancements in pharmaceutical formulations, enhancing the efficacy and purity of medications.
Collaborations
He has collaborated with notable colleagues, including Teng-Ko Ngooi and Casimir G Antczak, to further his research and development efforts in the pharmaceutical industry.
Conclusion
Jeffry D McGolrick's innovative work in the preparation of ranitidine hydrochloride showcases his valuable contributions to pharmaceutical chemistry. His patent reflects a commitment to improving drug formulation processes, which can have a lasting impact on the industry.